Julie Wolf is a Partner at 2048 Ventures, focusing on bio and health. She previously served as Chief Science Officer at SOSV's IndieBio New York and holds a Ph.D. from the University of Minnesota.
At firms with a similar stage, sector and check size.
One email when Julie's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckJulie Wolf is a Partner at 2048 Ventures, focusing on bio and health. She previously served as Chief Science Officer at SOSV's IndieBio New York and holds a Ph.D. from the University of Minnesota.
Julie Wolf invests through 2048 Ventures, which writes checks of $500K to $3M at pre-seed.
A warm intro from a founder 2048 Ventures backed works best. A short LinkedIn note with one line on traction is the next best route.
Chief Science Officer at SOSV's IndieBio New York; Chief Science Officer at SOSV’s IndieBio New York.
Last updated 2026-10-15. Is this you? Ask for a correction.